Navigation Links
FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone
Date:3/3/2011

mechanism for anthracycline induced acute cardiotoxicity.  These novel pharmacologic differences may allow re-introduction of anthracycline like potency in the treatment of relapsed/refractory aggressive lymphoma without unacceptable rates of cardiotoxicity.

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable.  For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the market price of CTI's securities.  Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry, in general, and with pixantrone, in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL and/or other tumors as determined by the FDA and/or the EMA, that the FDA may request additional clinical trials, that if CTI conducts an additional clinical trial, it may not demonstrate the safety and effectiveness of pixantrone, that CTI cannot predict or guarantee the pace or geography of enrollment of its clinical trials, that CTI may not initiate a new clinical trial for pixantrone in 2011, that CTI cannot predict the outcome of the formal dispute resolution process, that the FDA may not make its decision on the appeal in the second quarter of 2011, that CTI's appeal may not b
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PDL BioPharma Announces European Patent Office Determination of Validity of PDLs European Patent is Final
2. Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
3. Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
4. ERT Announces the Appointment of Eric Schwartz as Chief Legal Officer
5. Siemens Appoints Overhage as New Chief Medical Informatics Officer
6. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
7. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
8. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
9. Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
10. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
11. 3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  Today, the National Mobility ... the 2015 National Mobility Awareness Month Local Heroes Contest ... Hero online entries that received 1.3 million votes. The ... , Toyota Mobility , and Valley Honda ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
(Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe Plumbing, ... in San Diego. Bill Howe offers all employees ample opportunity for education and ... most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego ...
(Date:6/30/2015)... ... , ... Some may define success as the sum of small efforts repeated ... Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and applauded by ... number of members also received honors at the national level. , For ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Psychiatric ... at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will offer ... premiere event for psychiatric-mental health nursing draws more than 1,500 health care professionals ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the leader in the ... health records system from the company exclusively dedicated to helping eye care professionals ... intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the ...
(Date:6/30/2015)... ... ... Purdy, the spokesperson for Dephinitive Systems LLC, announces today that the company will officially ... eXtra Operability (XO) which was chosen to reflect the company’s commitment to health care ... XO, based in Cleveland OH, is part of the Cadrillion Capital family of Healthcare ...
Breaking Medicine News(10 mins):Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Dephinitive Systems Is Getting a New Name 2
... Still Feel Targeted By Tobacco Advertising and Find It,Easy ... across Kansas will,rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the Campaign,for Tobacco-Free ... a list of local events, go to http://www.kickbuttsday.org/events ...
... Still Feel Targeted By Tobacco Advertising & Find It,Easy ... across Florida,will rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the,Campaign for Tobacco-Free ... a list of local events, go to, http://www.kickbuttsday.org/events )., ...
... 27 Marshall Erdman &,Associates (Erdman) was ... Healthcare,s" 2008 Construction & Design Survey. The ... industry; it,examines year-over-year sales, contracted square footage ... and number of architects, engineers,and interior designers., ...
... knowledge and building important international relationships is top ... DendriMed Research Director Dr Raisa Monteiro, when she ... in May. , One of two Australian life ... candidates for the prestigious 2008 Advancing BioBusiness Award, ...
... alliances that,lead to increased sales and are mutually ... selection of compatible partners. Companies,that succeed in alliance ... articulating the rationale behind the effort, and then,choosing ... Practices, LLC,s white paper "Generating Value From Strategic,Alliances ...
... Practice Information Management Software Introduces Comprehensive Patient and Information Tracking ... ... Back-Up, DALLAS, March 27 Eklin Medical Systems, a ... Practice Management software for veterinary care,(VIA(R)), is showcasing VIA,s new Hospital ...
Cached Medicine News:Health News:Kansas Kids 'Kick Butts' on April 2 2Health News:Kansas Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 2Health News:Florida Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 4Health News:'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company 2Health News:DendriMed scientist seeks to fast-track success 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: